Time course of cll gene mutant manifestation in the liver, spleen, and bone marrow of N-ethyl-N-nitrosourea-Treated big blue transgenic mice

Toxicological Sciences

Volumn 82, Issue 1, 2004, Pages 124-128

  Wang, Jianyong ^a,b   Liu, Xiaoli ^a   Heflich, Robert H ^a,b   Chen, Tao ^a,c  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c NCTR   (United States)

Author keywords

Big blue transgenic mice; Mutant manifestation; Mutation assay; N ethyl N nitrosourea

Indexed keywords

ETHYLNITROSOUREA; MUTANT PROTEIN; PROTEIN CII; UNCLASSIFIED DRUG; ALKYLATING AGENT; CII PROTEIN, BACTERIOPHAGE LAMBDA; MUTAGENIC AGENT; TRANSCRIPTION FACTOR; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CONTROLLED STUDY; FEMALE; FREQUENCY ANALYSIS; GENE INDUCTION; GENE MUTATION; LIVER; MOUSE; NONHUMAN; SAMPLING; SINGLE DRUG DOSE; SPLEEN; STATISTICAL SIGNIFICANCE; TISSUE SPECIFICITY; TRANSGENIC MOUSE; ANIMAL; DRUG EFFECT; GENETICS; METABOLISM; MUTAGEN TESTING; MUTAGENESIS; MUTATION; TIME;

ANIMALIA; MUS MUSCULUS;

ALKYLATING AGENTS; ANIMALS; BONE MARROW; ETHYLNITROSOUREA; FEMALE; LIVER; MICE; MICE, TRANSGENIC; MUTAGENESIS; MUTAGENICITY TESTS; MUTAGENS; MUTATION; SPLEEN; TIME FACTORS; TRANSCRIPTION FACTORS; VIRAL PROTEINS;

EID: 8444225729     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfh234     Document Type: Article

References (21)

1. Cameron, I. L. (1971). Cell proliferation and renewal in the mammalian body. In Cellular and Molecular Renewal in the Mammalian Body (I. L. Cameron and J. D. Thrasher, Eds.), pp. 45-85. Academic Press, New York.
2. Chen, T., Gamboa da Costa, G., Marques, M. M., Shelton, S. D., Beland, F. A., and Manjanatha, M. G. (2002). Mutations induced by alpha-hydroxytamoxifen in the lacI and cII genes of Big Blue transgenic rats. Carcinogenesis 23, 1751-1757.
3. Douglas, G. R., Jiao, J., Gingerich, J. D., Gossen, J. A., and Soper, L. M. (1995). Temporal and molecular characteristics of mutations induced by ethylnitrosourea in germ cells isolated from seminiferous tubules and in spermatozoa of lacZ transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 92, 7485-7489.
4. Douglas, G. R., Jiao, J., Gingerich, J. D., Soper, L. M., and Gossen, J. A. (1996). Temporal and molecular characteristics of lac mutations in somatic tissues of trasgenic mice. Environ. Mol. Mutagen. 28, 317-324.
5. Hachiya, N., Yajima, N., Hatakeyama, S., Yuno, K., Okada, N., Umeda, Y., Wakata, A., and Motohashi, Y. (1999). Induction of lacZ mutation by 7,12-dimethylbenz[a]anthracene in various tissues of transgenic mice. Mutat. Res. 444, 283-295.
6. Hara, T., Hirano, K., Hirano, N., Tamura, H., Sui, H., Shibuya, T., Hyogo, A., Hirashio, T., Tokai, H., Yamashita, Y., et al. (1999). Mutation induction by N -propyl-N-nitrosourea in eight MutaMouse organs. Mutat. Res. 444, 297-307.
7. Heddle, J. A. (1999). Mutant manifestation: The time factor in somatic mutagenesis. Mutagenesis 14, 1-3.
8. Heddle, J. A., Martus, H. J., and Douglas, G. R. (2003). Treatment and sampling protocols for transgenic mutation assays. Environ. Mol. Mutagen. 41, 1-6.
9. Heddle, J. A., and Swiger, R. R. (1996). Risk estimation from somatic mutation assays. Mutat. Res. 365, 107-117.
10. Jakubczak, J. L., Merlino, G., French, J. E., Muller, W. J., Paul, B., Adhya, S., and Garges, S. (1996). Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target. Proc. Natl. Acad. Sci. U.S.A. 93, 9073-9078.
11. 6-methylguanine in bone marrow and not in the spleen. Carcinogenesis 17, 2183-2191.
12. Mientjes, E. J., Luiten-Schuite, A., van der Wolf, E., Borsboom, Y., Bergmans, A., Berends, F., Lohman, P. H., Baan, R. A., and van Delft, J. H. (1998). DNA adducts, mutant frequencies, and mutation spectra in various organs of lambda lacZ mice exposed to ethylating agents. Environ. Mol. Mutagen. 31, 18-31.
13. Sun, B., and Heddle, J. A. (1999). The relationship between mutant frequency and time in vivo: Simple predictions for any tissue, cell type, or mutagen. Mutat. Res. 425, 179-183.
14. Sun, B., Shima, N., and Heddle, J. A. (1999). Somatic mutation in the mammary gland: Influence of time and estrus. Mutat Res 427, 11-19.
15. Suzuki, T., Itoh, S., Nakajima, M., Hachiya, N., and Hara, T. (1999). Target organ and time-course in the mutagenicity of five carcinogens in MutaMouse: A summary report of the second collaborative study of the transgenic mouse mutation assay by JEMS/MMS. Mutat. Res. 444, 259-268.
16. Swiger, R. R., Cosentino, L., Masumura, K. I., Nohmi, T., and Heddle, J. A. (2001). Further characterization and validation of gpt delta transgenic mice for quantifying somatic mutations in vivo. Environ. Mol. Mutagen. 37, 297-303.
17. Swiger, R. R., Cosentino, L., Shima, N., Bielas, J. H., Cruz-Munoz, W., and Heddle, J. A. (1999). The cII locus in the MutaMouse system. Environ. Mol. Mutagen. 34, 201-207.
18. Tao, K. S., Urlando, C., and Heddle, J.A. (1993). Comparison of somatic mutation in a transgenic versus host locus. Proc. Natl. Acad. Sci. U.S.A. 90, 10681-10685.
19. Thybaud, V., Dean, S., Nohmi, T., de Boer, J., Douglas, G. R., Glickman, B. W., Gorelick, N. J., Heddle, J. A., Heflich, R. H., Lambert, I., et al. (2003). In vivo transgenic mutation assays. Mutat. Res. 540, 141-151.
20. Walker, V. E., Jones, I. M., Crippen, T. L., Meng, Q., Walker, D. M., Bauer, M. J., Reilly, A. A., Tates, A. D., Nakamura, J., Upton, P. B., et al. (1999). Relationships between exposure, cell loss and proliferation, and manifestation of Hprt mutant T cells following treatment of preweanling, weanling, and adult male mice with N-ethyl-N-nitrosourea [see comments]. Mutat. Res. 431, 371-388.
21. Zimmer, D. M., Harbach, P. R., Mattes, W. B., and Aaron, C. S. (1999). Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice. Environ. Mol. Mutagen. 33, 249-256.